Advanced search
Publication Cover
Biotechnology & Biotechnological Equipment Volume 36, 2022 - Issue 1
Submit an article Journal homepage
832
Views
0
CrossRef citations to date
0
Altmetric
Articles

Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study

Miglena Donevaa Department of Organization and Economics of Pharmacy Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
,
Petya Milushewaa Department of Organization and Economics of Pharmacy Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaCorrespondence[email protected]
,
Maria Dimitrovaa Department of Organization and Economics of Pharmacy Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
,
Maria Kamushevaa Department of Organization and Economics of Pharmacy Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaORCID Iconhttps://orcid.org/0000-0002-4379-5283
ORCID Icon,
Jordan Stoitchkovb Medical Center, National Cardiology Hospital, Sofia, Bulgaria
,
Guenka Petrovaa Department of Organization and Economics of Pharmacy Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
,
Kremena Naydenovac Department of Allergy and Asthma, University Hospital Alexandrovska, Sofia, Bulgaria
,
Borislava Krushevac Department of Allergy and Asthma, University Hospital Alexandrovska, Sofia, Bulgaria
,
Vasil Dimitrovc Department of Allergy and Asthma, University Hospital Alexandrovska, Sofia, Bulgaria
&
Dragana Lakicd Department of Social Pharmacy and Pharmaceutical Legislation, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
 show all
Pages 481-488 | Received 27 Mar 2022, Accepted 04 Jul 2022, Published online: 20 Jul 2022

References

  • Pawankar R, Canonica GW, Holgate ST, et al., editors. World Allergy Organization (WAO) White Book on Allergy. From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. Milwaukee: WAO; 2011. p. 1–216. Available from: http://www.ginasthma.org/)
  • To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204.
  • Jarvis D, Newson R, Lotvall J, et al. Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Eur J Allergy Clin Immunol. 2012;67(1):91–98.
  • Zdraveska M, Dimitrievska D, Todevski D, et al. Joint incidence of asthma and rhinitis in macedonia. Open Respir Med J. 2015;9:52–58.
  • Milushewa P, Doneva M, Petrova G. Availability and reimbursement of biological products for severe asthma in Bulgaria. SAGE Open Med. 2020;8:2050312120951067–2050312120951067.
  • Mileva G, Popov T, Staneva M, et al. Frequency and characteristics of allergic diseases in Bulgaria. Allergy Asthma. 2000;5:3–32.
  • Anum PO, Anto BP, Forson AG. Structured pharmaceutical care improves the health-related quality of life of patients with asthma. J Pharm Policy Pract. 2017;10:8–15.
  • Böhmer M, Brandl M, Brandstetter S, et al. Factors associated with generic health-related quality of life in adult asthma patients in Germany: cross-sectional study. J Asthma. 2017;54(3):325–334.
  • Petkova V. Pharmaceutical care for asthma patients: a community pharmacy-based pilot project. Allergy Asthma Proc. 2008;29(1):55–61.
  • Chiner E, Hernández C, Blanco-Aparicio M, et al. Patient perspectives of the influence of severe and non-severe asthma on their quality of life: a national survey of asthma patients in Spain. Clin Respir J. 2022;16(2):130–141.
  • Clark VL, Gibson PG, McDonald VM. What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance. ERJ Open Res. 2021;7(1):00497–2020.
  • Milenković B, Ristić S, Mirović D, et al. Validation of the serbian version of the asthma control test. Vojnosanit Pregl. 2019;76:1029–1036.
  • Ilmarinen P, Juboori H, Tuomisto LE, et al. Effect of asthma control on general health-related quality of life in patients diagnosed with adult-onset asthma. Sci Rep. 2019;9(1):16107.
  • Burden A. European Respiratory Society, Global Initiative for Asthma (GINA): global strategy for asthma management and prevention. Update 2014 and Online Appendix. Available from: https://ginasthma.org/wp-content/uploads/2019/01/2014-GINA.pdf
  • Chen H, Gould M, Blanc P, et al. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol. 2007;120(2):396–401.
  • Bauchau V, Durham S. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24(5):758–764.
  • Vianello A, Caminat M, Andretta M, et al. L. Prevalence of severe asthma according to the drug regulatory agency perspective: an Italian experience. World Allergy Organ J. 2019;12(4):100032–100033.
  • Air Pollution and Mortality in BG (http://env-health.org/IMG/pdf/heal_briefing_air_bulgaria_eng.pdf). Available from: https://www.webmd.com/asthma/asthma-risk-factors
  • Taube C, Bramlage P, Hofer A, et al. Prevalence of oral corticosteroid use in the German severe asthma population. ERJ Open Res. 2019;5(4):00092–2019.
  • Plaza V, Giner J, Calle M, et al. Impact of patient satisfaction with his or her inhaler on adherence and asthma control. Allergy Asthma Proc. 2018;39(6):437–444.
  • Dimitrova D, Youroukova V. Severe asthma - definitions, immunological characterization and molecular- targeted therapy. Thorac Med. 2015;7:9–25.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.